Treatment with etidronate or alendronate in postmenopausal osteoporosis.

被引:0
|
作者
Lissens, MA [1 ]
机构
[1] State Univ Ghent Hosp, B-9000 Ghent, Belgium
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
F340
引用
收藏
页码:S277 / S277
页数:1
相关论文
共 50 条
  • [31] A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis
    Stevenson, M
    Jones, ML
    De Nigris, E
    Brewer, N
    Davis, S
    Oakley, J
    HEALTH TECHNOLOGY ASSESSMENT, 2005, 9 (22) : 1 - +
  • [32] BONE-TARGETING DELIVERY OF ALENDRONATE FOR THE TREATMENT OF OSTEOPOROSIS.
    Chen, Shen-Mao
    Zhao, Lingling
    Lee, Tung-Chun
    Liu, Chaozong
    TISSUE ENGINEERING PART A, 2022, 28 : S228 - S228
  • [33] Alendronate in the treatment of primary hyperparathyroid-related osteoporosis.
    Parker, CR
    Blackwell, PJ
    Hosking, DJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 1998, 13 (09) : 1508 - 1508
  • [34] Two year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis.
    Rizzoli, R
    Roux, C
    Greenspan, S
    Bone, H
    Schnitzer, T
    Watts, N
    Adami, S
    Uebelhart, B
    Peverly, C
    Kaur, A
    Wu, M
    Orloff, J
    Santora, A
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S527 - S527
  • [35] A Meta-analysis of Etidronate for the Treatment of Postmenopausal Osteoporosis
    A. Cranney
    G. Guyatt
    N. Krolicki
    V. Welch
    L. Griffith
    J. D. Adachi
    B. Shea
    P. Tugwell
    G. Wells
    Osteoporosis International, 2001, 12 : 140 - 151
  • [36] Effect of Alendronate and Calcitonin on biochemical markers of bone formation in postmenopausal women with osteoporosis.
    Colak, O
    Alatas, Ö
    Bilgen, N
    Tosunoglu, F
    Sagir, F
    Sunal, E
    CLINICAL CHEMISTRY, 2000, 46 (06) : A21 - A22
  • [37] A meta-analysis of etidronate for the treatment of postmenopausal osteoporosis
    Cranney, A
    Guyatt, G
    Krolicki, N
    Welch, V
    Griffith, L
    Adachi, JD
    Shea, B
    Tugwell, P
    Wells, G
    OSTEOPOROSIS INTERNATIONAL, 2001, 12 (02) : 140 - 151
  • [38] ETIDRONATE DISODIUM IN POSTMENOPAUSAL OSTEOPOROSIS
    HEANEY, RP
    SAVILLE, PD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1976, 20 (05) : 593 - 604
  • [39] ETIDRONATE FOR POSTMENOPAUSAL OSTEOPOROSIS - REPLY
    STORM, T
    THAMSBORG, G
    STEINICHE, T
    GENANT, HK
    SORENSEN, OH
    NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (17): : 1210 - 1210
  • [40] Cyclical alendronate treatment in postmenopausal women with osteoporosis
    Kösüs, A
    Çapar, M
    Kösüs, N
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2005, 91 (02) : 182 - 184